Category BUSINESS

VDYNE

VDYNE Secures FDA Approval to Launch TRIVITA1 Pivotal IDE Trial for Its Transcatheter Tricuspid Valve Replacement System

VDYNE Secures FDA IDE Approval to Advance Pivotal TRIVITA1 Trial for Transcatheter Tricuspid Valve Replacement System VDYNE, Inc., a privately held medical device innovator focused on next-generation transcatheter valve therapies,…

Read MoreVDYNE Secures FDA Approval to Launch TRIVITA1 Pivotal IDE Trial for Its Transcatheter Tricuspid Valve Replacement System